Reproductive Health
News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
Sema4 Q3 Revenues Rise 12 Percent
For the quarter ended Sept. 30, the firm reported $43.2 million in revenues, up from $38.6 million in Q3 of 2020 and beating the average Wall Street estimate.
As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests.
Although demand for the firm's COVID-19 testing declined in H1, other diagnostic areas and its international business have grown.
Bionano Genomics, NuProbe Global Collaborate on Reproductive Health, Cancer Liquid Biopsies
The firms will integrate NuProbe's quantitative amplicon sequencing and blocker displacement amplification technologies with Bionano's Saphyr optical genome mapping platform.
BGI Genomics H1 Revenues Fall 11 Percent on COVID-19 Testing Decline
The firm's other businesses saw steady growth, with cancer prevention revenues up 94 percent and infection prevention and control revenues more than tripling.